Goldman Sachs Group Inc 2seventy Bio, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,294,901 shares of TSVT stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,294,901
Previous 4,219,817 1.78%
Holding current value
$11 Million
Previous $19.9 Million 36.6%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$2.89 - $5.21 $216,992 - $391,187
75,084 Added 1.78%
4,294,901 $12.6 Million
Q3 2024

Nov 14, 2024
BUY
$3.85 - $5.05 $315,592 - $413,958
81,972 Added 1.98%
4,219,817 $19.9 Million
Q2 2024

Aug 13, 2024
SELL
$3.6 - $5.79 $302,176 - $486,001
-83,938 Reduced 1.99%
4,137,845 $15.9 Million
Q1 2024

May 15, 2024
SELL
$3.09 - $6.0 $886,882 - $1.72 Million
-287,017 Reduced 6.37%
4,221,783 $22.6 Million
Q4 2023

Feb 13, 2024
BUY
$1.57 - $4.58 $5.92 Million - $17.3 Million
3,772,556 Added 512.41%
4,508,800 $19.3 Million
Q3 2023

May 14, 2024
SELL
$3.14 - $11.2 $11.8 Million - $42.3 Million
-3,772,556 Reduced 83.67%
736,244 $2.89 Million
Q3 2023

Nov 14, 2023
SELL
$3.14 - $11.2 $2.79 Million - $9.95 Million
-888,008 Reduced 54.67%
736,244 $2.89 Million
Q2 2023

May 14, 2024
SELL
$8.45 - $12.48 $1.04 Million - $1.54 Million
-123,270 Reduced 7.05%
1,624,252 $16.4 Million
Q2 2023

Aug 14, 2023
SELL
$8.45 - $12.48 $1.04 Million - $1.54 Million
-123,270 Reduced 7.05%
1,624,252 $16.4 Million
Q1 2023

May 14, 2024
BUY
$9.21 - $14.98 $6.41 Million - $10.4 Million
696,379 Added 66.25%
1,747,522 $17.8 Million
Q1 2023

May 11, 2023
BUY
$9.21 - $14.98 $6.41 Million - $10.4 Million
696,379 Added 66.25%
1,747,522 $17.8 Million
Q4 2022

May 14, 2024
SELL
$8.57 - $17.0 $60,641 - $120,292
-7,076 Reduced 0.67%
1,051,143 $9.85 Million
Q4 2022

Feb 13, 2023
SELL
$8.57 - $17.0 $60,641 - $120,292
-7,076 Reduced 0.67%
1,051,143 $9.85 Million
Q3 2022

May 14, 2024
BUY
$12.56 - $17.54 $9.07 Million - $12.7 Million
721,910 Added 214.66%
1,058,219 $15.4 Million
Q3 2022

Nov 10, 2022
BUY
$12.56 - $17.54 $9.07 Million - $12.7 Million
721,910 Added 214.66%
1,058,219 $15.4 Million
Q2 2022

May 14, 2024
SELL
$10.55 - $18.81 $44 Million - $78.5 Million
-4,172,491 Reduced 92.54%
336,309 $4.44 Million
Q2 2022

Aug 15, 2022
BUY
$10.55 - $18.81 $2.31 Million - $4.12 Million
219,124 Added 186.99%
336,309 $4.44 Million
Q1 2022

May 16, 2022
SELL
$11.67 - $26.72 $4.57 Million - $10.5 Million
-391,237 Reduced 76.95%
117,185 $2 Million
Q4 2021

Feb 14, 2022
BUY
$13.77 - $42.56 $7 Million - $21.6 Million
508,422 New
508,422 $13 Million

Others Institutions Holding TSVT

# of Institutions
128
Shares Held
45M
Call Options Held
40.4K
Put Options Held
4.8K
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $96.6M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email